214 related articles for article (PubMed ID: 22146068)
1. Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study.
Ono H; Nishijima Y; Adachi N; Tachibana S; Chitoku S; Mukaihara S; Sakamoto M; Kudo Y; Nakazawa J; Kaneko K; Nawashiro H
Med Gas Res; 2011 Jun; 1(1):12. PubMed ID: 22146068
[TBL] [Abstract][Full Text] [Related]
2. Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator.
Lee XR; Xiang GL
Clin Neurol Neurosurg; 2018 Apr; 167():157-161. PubMed ID: 29501045
[TBL] [Abstract][Full Text] [Related]
3. Effect of Intravenous Thrombolysis on the Time Course of the Apparent Diffusion Coefficient in Acute Middle Cerebral Artery Infarction.
Kretzer L; Gräßel D; Bokemeyer MA; Günther A; Witte OW; Axer H; Ringer TM
J Neuroimaging; 2015; 25(6):978-82. PubMed ID: 25895155
[TBL] [Abstract][Full Text] [Related]
4. Clinical observation in edaravone treatment for acute cerebral infarction.
Sun Z; Xu Q; Gao G; Zhao M; Sun C
Niger J Clin Pract; 2019 Oct; 22(10):1324-1327. PubMed ID: 31607719
[TBL] [Abstract][Full Text] [Related]
5. The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury.
Itoh T; Satou T; Nishida S; Tsubaki M; Hashimoto S; Ito H
Neurotox Res; 2009 Nov; 16(4):378-89. PubMed ID: 19590930
[TBL] [Abstract][Full Text] [Related]
6. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
7. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
8. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
9. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical.
Abe S; Kirima K; Tsuchiya K; Okamoto M; Hasegawa T; Houchi H; Yoshizumi M; Tamaki T
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):186-91. PubMed ID: 14758002
[TBL] [Abstract][Full Text] [Related]
10. Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.
Kikuchi K; Kawahara KI; Uchikado H; Miyagi N; Kuramoto T; Miyagi T; Morimoto Y; Ito T; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada KI; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
Exp Ther Med; 2011 Sep; 2(5):771-775. PubMed ID: 22977573
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the free radical scavenger, edaravone, for motor palsy of acute lacunar infarction.
Ohta Y; Takamatsu K; Fukushima T; Ikegami S; Takeda I; Ota T; Goto K; Abe K
Intern Med; 2009; 48(8):593-6. PubMed ID: 19367054
[TBL] [Abstract][Full Text] [Related]
12. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.
Higashi Y
Expert Opin Pharmacother; 2009 Feb; 10(2):323-31. PubMed ID: 19236202
[TBL] [Abstract][Full Text] [Related]
13. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
[TBL] [Abstract][Full Text] [Related]
14. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
15. [Alterations of antiproliferative effects of serum obtained from patients with acute cerebral infarction treated with a radical scavenger, edaravone, with or without amlodipine using an in vitro cultured basilar artery smooth muscle cells].
Yamaguchi T; Ida T; Kobayashi T; Hiraga M; Oishi K; Uchida MK; Echizen H
Yakugaku Zasshi; 2004 Jan; 124(1):25-9. PubMed ID: 14768352
[TBL] [Abstract][Full Text] [Related]
16. Effects of Edaravone on Nitric Oxide, Hydroxyl Radicals and Neuronal Nitric Oxide Synthase During Cerebral Ischemia and Reperfusion in Mice.
Kawasaki H; Ito Y; Kitabayashi C; Tanaka A; Nishioka R; Yamazato M; Ishizawa K; Nagai T; Hirayama M; Takahashi K; Yamamoto T; Araki N
J Stroke Cerebrovasc Dis; 2020 Mar; 29(3):104531. PubMed ID: 31882337
[TBL] [Abstract][Full Text] [Related]
17. The free radical scavenger, edaravone, ameliorates delayed neuropsychological sequelae after acute carbon monoxide poisoning in rabbits.
Qingsong W; Yeming G; Xuechun L; Hongjuan L; Jing W
Undersea Hyperb Med; 2013; 40(3):223-9. PubMed ID: 23789557
[TBL] [Abstract][Full Text] [Related]
18. Effect of free radical scavenger, edaravone, for patients with carbon monoxide poisoning.
Mori K; Beppu T; Fujisawa Y; Onodera M; Ogasawara K; Sasaki M; Ehara S; Sakai A; Endo S
Clin Neurol Neurosurg; 2015 Dec; 139():56-61. PubMed ID: 26368269
[TBL] [Abstract][Full Text] [Related]
19. Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus.
Garcia CAB; Catalão CHR; Machado HR; Júnior IM; Romeiro TH; Peixoto-Santos JE; Santos MV; da Silva Lopes L
Childs Nerv Syst; 2017 Mar; 33(3):419-428. PubMed ID: 27988876
[TBL] [Abstract][Full Text] [Related]
20. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
